{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:44:50Z","timestamp":1764510290006,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3327,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.bbmt.2005.10.021","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T15:16:15Z","timestamp":1141226175000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytoreduction of Lymphoid Malignancies and Mobilization of Blood Hematopoietic Progenitor Cells with High Doses of Cyclophosphamide and Etoposide Plus Filgrastim"],"prefix":"10.1016","volume":"12","author":[{"given":"Lloyd","family":"Damon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Tolaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willis","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Thomas","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt","family":"Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delvyn","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Linker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.10.021_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(88)92012-0","article-title":"Granulocyte-macrophage colony stimulating factor expands the circulating hematopoietic progenitor cell compartment in man","volume":"1","author":"Socinski","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.10.021_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(89)90711-3","article-title":"Granulocyte-macrophage colony stimulating factor to harvest circulating hematopoietic progenitor cells for autotransplantation","volume":"2","author":"Gianni","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.10.021_bib3","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1200\/JCO.1994.12.10.2176","article-title":"High-dose therapy followed by autologous peripheral-blood progenitor-cell transplantation for patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood progenitor cells","volume":"12","author":"Nademanee","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib4","first-page":"442","article-title":"Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic progenitor cells from the peripheral blood","volume":"18","author":"To","year":"1990","journal-title":"Exp Hematol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib5","first-page":"106","article-title":"Optimization of peripheral blood progenitor cell mobilization","volume":"14","author":"Demirer","year":"1996","journal-title":"Progenitor Cell"},{"key":"10.1016\/j.bbmt.2005.10.021_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1703912","article-title":"G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma","volume":"31","author":"Milone","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1098-1101(2000)15:4<217::AID-JCA1>3.0.CO;2-Z","article-title":"Peripheral blood progenitor cell mobilization in three groups of subjects","volume":"15","author":"Linn","year":"2000","journal-title":"J Clin Apheresis."},{"key":"10.1016\/j.bbmt.2005.10.021_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0955-3886(00)00072-2","article-title":"Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield","volume":"23","author":"Marques","year":"2000","journal-title":"Transfus Sci."},{"key":"10.1016\/j.bbmt.2005.10.021_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bmt.1702426","article-title":"Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization","volume":"25","author":"Vela-Ojeda","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib10","first-page":"1409","article-title":"Peripheral blood progenitor cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases","volume":"7","author":"Campos","year":"1993","journal-title":"Leukemia."},{"key":"10.1016\/j.bbmt.2005.10.021_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s002770000235","article-title":"High-dose etoposide phosphate and G-CSF mobilizes peripheral blood progenitor cells in patients that previously failed to mobilize","volume":"80","author":"Junghanss","year":"2001","journal-title":"Ann Hematol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/152581600419053","article-title":"Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient progenitor cells with cyclophosphamide and G-CSF","volume":"9","author":"Scheid","year":"2000","journal-title":"J Hematother Stem Cell Res."},{"key":"10.1016\/j.bbmt.2005.10.021_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1083-8791(00)70052-8","article-title":"Autologous progenitor cell transplantation for acute myeloid leukemia in first remission","volume":"6","author":"Linker","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2400753","article-title":"Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission","volume":"11","author":"Schiller","year":"1997","journal-title":"Leukemia."},{"key":"10.1016\/j.bbmt.2005.10.021_bib15","first-page":"763","article-title":"Mobilization of peripheral blood progenitor cells by high-dose Ara C, VP-16 and recombinant human granulocyte colony-stimulating factor","volume":"15","author":"Shimazaki","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1701920","article-title":"Use of peripheral blood progenitor cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells","volume":"24","author":"Visani","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib17","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood.V82.7.2239.2239","article-title":"Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin\u2019s lymphoma","volume":"82","author":"Pettengell","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.021_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bmt.1701422","article-title":"Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administrated following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood progenitor cells","volume":"22","author":"Hohaus","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2141.1998.00865.x","article-title":"Mobilizing peripheral blood progenitor cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients","volume":"102","author":"Kroger","year":"1998","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s004320050180","volume":"124","author":"Vogel","year":"1998","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1701192","article-title":"Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma","volume":"21","author":"Aurlien","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bmt.1701592","article-title":"Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma","volume":"23","author":"Mayer","year":"1999","journal-title":"Bone Marrow Transplant."},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.10.021_bib23","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/annonc\/mdg702","article-title":"Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma","volume":"14","author":"Zelenetz","year":"2003","journal-title":"Ann Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V76.3.473.473","article-title":"High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy","volume":"76","author":"Brown","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.021_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1537-2995.1997.37997454014.x","article-title":"Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor","volume":"37","author":"Weaver","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2005.10.021_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000421-199808000-00019","article-title":"A randomized trial of mobilization of peripheral blood progenitor cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy","volume":"21","author":"Weaver","year":"1998","journal-title":"Am J Clin Oncol."},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2005.10.021_bib27","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.bmt.1702865","article-title":"Mobilization of peripheral blood progenitor cells following myelosuppressive chemotherapy","volume":"27","author":"Weaver","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2000.18.1.43","article-title":"Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood progenitor cells","volume":"18","author":"Weaver","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1703653","article-title":"Cyclophosphamide, etoposide, and G-CSF to mobilize peripheral blood progenitor cells for autologous progenitor cell transplantation in patients with lymphoma","volume":"30","author":"Mollee","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib30","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous progenitor-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2005.10.021_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2141.2003.04646.x","article-title":"Survival after relapse following tandem autotransplants in multiple myeloma patients","volume":"123","author":"Fassus","year":"2003","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1605::AID-CNCR25>3.0.CO;2-0","article-title":"Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer","volume":"79","author":"Broun","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.10.021_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1703008","article-title":"Double dose-intensive chemotherapy with autologous progenitor cell support for relapsed and refractory testicular cancer","volume":"27","author":"Ayash","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.10.021_bib34","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1200\/JCO.1990.8.11.1782","article-title":"A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer","volume":"8","author":"Wallerstein","year":"1990","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.1994.12.1.37","article-title":"Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer","volume":"12","author":"Ayash","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Sutherland","year":"1996","journal-title":"J Hematother."},{"year":"2003","series-title":"StemCell Quality Control Technical Manual. Version 1.1.2","key":"10.1016\/j.bbmt.2005.10.021_bib37"},{"key":"10.1016\/j.bbmt.2005.10.021_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00280-003-0758-x","article-title":"Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule","volume":"53","author":"Damon","year":"2004","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.bbmt.2005.10.021_bib39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol."},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.10.021_bib40","first-page":"706a","article-title":"Autologous bone marrow transplant (ABMT) for non-Hodgkins (NHL) and Hodgkins (HD) lymphoma using a thiotepa-based preparative regimen","volume":"84","author":"Damon","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.021_bib41","first-page":"76","article-title":"Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin\u2019s lymphoma","volume":"2","author":"Stockerl-Goldstein","year":"1996","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105007251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105007251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:17Z","timestamp":1761056777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105007251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1083879105007251"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoreduction of Lymphoid Malignancies and Mobilization of Blood Hematopoietic Progenitor Cells with High Doses of Cyclophosphamide and Etoposide Plus Filgrastim","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}